Tempest Therapeutics, INC S-1 registration statements
Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.
NASDAQ
Tempest Therapeutics, Inc. has filed an S-1 registration statement to allow Lincoln Park Capital Fund, LLC to sell up to 8,910,579 shares of common stock, potentially raising up to $50 million.
NASDAQ
Tempest Therapeutics, a clinical-stage biotechnology company, filed an S-1 registration statement for the resale of 1,172,414 common shares by a selling stockholder, issuable upon warrant exercise.